NASDAQ · CXAIW

CXApp Inc.

$0.05 -$0.00 (-2.55%) 1D Pre-market

Key Metrics

Market cap
P/E · TTM
$4.31M
Revenue · TTM
−$15.86M
Net income
EPS · TTM
Dividend yield
Free cash flow −$11.64M
Beta · 1Y 1.19
EBITDA · TTM −$17.91M
Gross margin 86.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 4
    The stock moved +47.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 4
  • Mar 30
    From its Mar 11 high, the share price fell 62%.

    Peak close $0.07 on Mar 11; trough close $0.03 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -62%
  • Mar 30
    The stock moved -45.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.02 – $0.14
Avg volume · 20D95.5K
Net cash
Book value / share
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About CXApp Inc.
IPO dateFeb 4, 2021
Employees35

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 86.4%
Operating -416.7%
Net -368.1%
FCF -270.0%
ROE / ROIC -99.5% · -503.5%

Financial Health

Current ratio2.28
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$7.98M

Cash Flow · TTM

Operating CF −$11.61M
Capex −$23.00K
Free cash flow −$11.64M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings